NCT06072950

Brief Summary

Background: Increasing opioid misuse is a worldwide problem. About 10% of opioid misusers are primarily exposed to opioids at the Emergency Department (ED). This study was conducted to determine the feasibility for a clinical trial investigating the effect of Virtual Reality therapy on opioid consumption at the ED. Methods: Adult patients were included when primarily seen by the Emergency Physician and presenting with a NRS pain score ≥4. Main objective was to identify the target population and evaluate outcome measures to sustain a trial incorporating the Oral Morphine Equivalent (OME) at the ED as the primary endpoint. Primary outcome was mean OME administered at the ED. Secondary outcomes included NRS pain scores, main symptoms and type of analgesics administered at the ED.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
149

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2023

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 18, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
Last Updated

October 10, 2023

Status Verified

September 1, 2023

Enrollment Period

7 months

First QC Date

September 18, 2023

Last Update Submit

October 3, 2023

Conditions

Keywords

Emergency DepartmentPain at restOpioid use

Outcome Measures

Primary Outcomes (1)

  • Opioid use

    Opioids use of patients during their stay at Emergency Department (yes/no)

    throughout study participation, up to 8 hours

Secondary Outcomes (12)

  • Oral morphine equivalent

    throughout study participation, up to 8 hours

  • Administered analgesics

    throughout study participation, up to 8 hours

  • Pain acceptability

    Asked at moment of admittance and at discharge, up to 6 hours after inclusion

  • Reason why patients finds pain acceptable

    Assessed upon admittance

  • Patients desire for analgesics

    Asked at moment of admittance and at discharge, up to 6 hours after inclusion

  • +7 more secondary outcomes

Study Arms (1)

Patient with NRS pain at rest being 4 or higher

Patient with NRS pain at rest being 4 or higher, primarily treated by emergency physician, internist, or surgeon. All patients receive usual care, no interventions are administered.

Other: Usual care

Interventions

Patients received usual care

Patient with NRS pain at rest being 4 or higher

Eligibility Criteria

Age16 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We aim to include all patients ≥16 years, who are admitted to the ED of the Radboudumc and primarily seen by an ED physician.

You may qualify if:

  • Patient ≥16 years admitted to ED and identified by an Emergency Physician (EP)
  • NRS pain score ≥4
  • Patient is willing and able to comply with the study protocol

You may not qualify if:

  • Patients initially treated by another physician than the EP.
  • EMV \< 14
  • History of dementia, seizures
  • Severe hearing/visual impairment not corrected
  • Headwounds or damaged skin with which comfortable and hygienic use is not possible.
  • Presentation to ED because of chronic pain (≥3 months) exacerbation
  • Chronic opioids use (≥3 months)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud university medical center

Nijmegen, Gelderland, 6525 GA, Netherlands

Location

MeSH Terms

Conditions

PainAcute PainEmergencies

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2023

First Posted

October 10, 2023

Study Start

February 13, 2023

Primary Completion

September 4, 2023

Study Completion

September 4, 2023

Last Updated

October 10, 2023

Record last verified: 2023-09

Locations